| Elizabeth Gosselin, SLP | |
|
382 S Main St, Cheshire, CT 06410-3115 | |
| (203) 250-9663 | |
| (203) 699-9641 |
| Full Name | Elizabeth Gosselin |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 382 S Main St, Cheshire, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467094565 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Gosselin, SLP 382 S Main St, Cheshire, CT 06410-3115 Ph: (203) 250-9663 | Elizabeth Gosselin, SLP 382 S Main St, Cheshire, CT 06410-3115 Ph: (203) 250-9663 |
News Archive
K2M, Inc., the largest privately held spinal device company in the world focused on developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced that with the recent addition of multiple breakthrough technologies, K2M offers a market leading comprehensive product portfolio to be exhibited at the North American Spine Society (NASS) Annual Meeting.
The 2010 Meeting of the Mainz University Research Focus on Interdisciplinary Neurosciences will be held on "Cognitive Enhancement Ethics and Society".
Nanoparticles tailored to latch onto blood platelets rapidly create healthy clots and nearly double the survival rate in the vital first hour after injury, new research shows.
Ascenta Therapeutics announced today that encouraging results from a Phase I dose-escalation study of two combination therapy regimens containing AT-101, an oral, pan-Bcl-2 inhibitor, in patients with the most malignant type of brain tumor, were described in an oral presentation at the 2009 Joint Meeting of the Society for NeuroOncology (SNO) and AANS/CNS Section on Tumors in New Orleans, Louisiana (Concurrent Session VI: Radiation Oncology, October 23, 2009; Abstract # 449).
As British cyclist Chris Froome celebrates his third Tour de France victory, research from the University of Kent and Australian collaborators shows for the first time that elite endurance athletes have superior ability to resist mental fatigue.
› Verified 8 days ago
Colleen A Canas, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 105 Mountain Rd, Cheshire, CT 06410 Phone: 203-213-1326 | |
Mrs. Megan Porto, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 382 S Main St, Cheshire, CT 06410 Phone: 203-250-9663 | |
Mikayla Macclain, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 382 S Main St, Cheshire, CT 06410 Phone: 203-250-9663 Fax: 203-699-9641 | |
Sara Barnick, SPEECH THERAPIST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 382 S Main St, Cheshire, CT 06410 Phone: 203-250-9663 Fax: 203-699-9641 | |
Mrs. Colleen Cull, M.S. CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 132 Elm St, Cheshire, CT 06410 Phone: 203-250-9663 | |
Hannah Wilson, SPEECH THERAPIST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 382 S Main St, Cheshire, CT 06410 Phone: 203-250-9663 Fax: 203-699-9641 | |
Amanda Rodriguez, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 382 S Main St, Cheshire, CT 06410 Phone: 203-250-9663 |